These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11265225)

  • 1. [Gene therapy of X-linked severe combined immunologic deficiency (SCID-X1)].
    Hacein-Bey S; Gross F; Nusbaum P; Yvon E; Fischer A; Cavazzana-Calvo M
    Pathol Biol (Paris); 2001 Feb; 49(1):57-66. PubMed ID: 11265225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of interleukin-2 (IL-2), IL-7, and IL-15 in natural killer cell differentiation from cord blood hematopoietic progenitor cells and from gamma c transduced severe combined immunodeficiency X1 bone marrow cells.
    Cavazzana-Calvo M; Hacein-Bey S; de Saint Basile G; De Coene C; Selz F; Le Deist F; Fischer A
    Blood; 1996 Nov; 88(10):3901-9. PubMed ID: 8916956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of an infant with X-linked severe combined immunodeficiency (SCID-X1) by gene therapy in Australia.
    Ginn SL; Curtin JA; Kramer B; Smyth CM; Wong M; Kakakios A; McCowage GB; Watson D; Alexander SI; Latham M; Cunningham SC; Zheng M; Hobson L; Rowe PB; Fischer A; Cavazzana-Calvo M; Hacein-Bey-Abina S; Alexander IE
    Med J Aust; 2005 May; 182(9):458-63. PubMed ID: 15865589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease.
    Cavazzana-Calvo M; Hacein-Bey S; de Saint Basile G; Gross F; Yvon E; Nusbaum P; Selz F; Hue C; Certain S; Casanova JL; Bousso P; Deist FL; Fischer A
    Science; 2000 Apr; 288(5466):669-72. PubMed ID: 10784449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. gamma-c gene transfer into SCID X1 patients' B-cell lines restores normal high-affinity interleukin-2 receptor expression and function.
    Hacein-Bey H; Cavazzana-Calvo M; Le Deist F; Dautry-Varsat A; Hivroz C; Rivière I; Danos O; Heard JM; Sugamura K; Fischer A; De Saint Basile G
    Blood; 1996 Apr; 87(8):3108-16. PubMed ID: 8605324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector.
    Gaspar HB; Parsley KL; Howe S; King D; Gilmour KC; Sinclair J; Brouns G; Schmidt M; Von Kalle C; Barington T; Jakobsen MA; Christensen HO; Al Ghonaium A; White HN; Smith JL; Levinsky RJ; Ali RR; Kinnon C; Thrasher AJ
    Lancet; 2004 Dec 18-31; 364(9452):2181-7. PubMed ID: 15610804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. gammac gene transfer in the presence of stem cell factor, FLT-3L, interleukin-7 (IL-7), IL-1, and IL-15 cytokines restores T-cell differentiation from gammac(-) X-linked severe combined immunodeficiency hematopoietic progenitor cells in murine fetal thymic organ cultures.
    Hacein-Bey S; Basile GD; Lemerle J; Fischer A; Cavazzana-Calvo M
    Blood; 1998 Dec; 92(11):4090-7. PubMed ID: 9834214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplantation of X-linked severe combined immunodeficient dogs with CD34+ bone marrow cells.
    Hartnett BJ; Yao D; Suter SE; Ellinwood NM; Henthorn PS; Moore PE; McSweeney PA; Nash RA; Brown JD; Weinberg KI; Felsburg PJ
    Biol Blood Marrow Transplant; 2002; 8(4):188-97. PubMed ID: 12014808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retroviral transduction of IL2RG into CD34(+) cells from X-linked severe combined immunodeficiency patients permits human T- and B-cell development in sheep chimeras.
    Tsai EJ; Malech HL; Kirby MR; Hsu AP; Seidel NE; Porada CD; Zanjani ED; Bodine DM; Puck JM
    Blood; 2002 Jul; 100(1):72-9. PubMed ID: 12070011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy.
    Hacein-Bey-Abina S; Le Deist F; Carlier F; Bouneaud C; Hue C; De Villartay JP; Thrasher AJ; Wulffraat N; Sorensen R; Dupuis-Girod S; Fischer A; Davies EG; Kuis W; Leiva L; Cavazzana-Calvo M
    N Engl J Med; 2002 Apr; 346(16):1185-93. PubMed ID: 11961146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A self-inactivating lentiviral vector for SCID-X1 gene therapy that does not activate LMO2 expression in human T cells.
    Zhou S; Mody D; DeRavin SS; Hauer J; Lu T; Ma Z; Hacein-Bey Abina S; Gray JT; Greene MR; Cavazzana-Calvo M; Malech HL; Sorrentino BP
    Blood; 2010 Aug; 116(6):900-8. PubMed ID: 20457870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal evidence for the transduction of CD34+ cells with lymphomyeloid differentiation potential and self-renewal capacity in the SCID-X1 gene therapy trial.
    Schmidt M; Hacein-Bey-Abina S; Wissler M; Carlier F; Lim A; Prinz C; Glimm H; Andre-Schmutz I; Hue C; Garrigue A; Le Deist F; Lagresle C; Fischer A; Cavazzana-Calvo M; von Kalle C
    Blood; 2005 Apr; 105(7):2699-706. PubMed ID: 15585650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A partial deficiency of interleukin-7R alpha is sufficient to abrogate T-cell development and cause severe combined immunodeficiency.
    Roifman CM; Zhang J; Chitayat D; Sharfe N
    Blood; 2000 Oct; 96(8):2803-7. PubMed ID: 11023514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retroviral vector for gene therapy of X-linked severe combined immunodeficiency syndrome.
    Qazilbash MH; Walsh CE; Russell SM; Noguchi M; Mann MM; Leonard WJ; Liu JM
    J Hematother; 1995 Apr; 4(2):91-8. PubMed ID: 7633846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Transplantation of genetically modified cells in the treatment of children with SCID: great hopes and recent disappointments].
    Smogorzewska EM; Weinberg KI; Kohn DB
    Med Wieku Rozwoj; 2003; 7(1):27-34. PubMed ID: 13130167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro correction of JAK3-deficient severe combined immunodeficiency by retroviral-mediated gene transduction.
    Candotti F; Oakes SA; Johnston JA; Notarangelo LD; O'Shea JJ; Blaese RM
    J Exp Med; 1996 Jun; 183(6):2687-92. PubMed ID: 8676091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X-linked SCID and other defects of cytokine pathways.
    Uribe L; Weinberg KI
    Semin Hematol; 1998 Oct; 35(4):299-309. PubMed ID: 9801259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1.
    Mamcarz E; Zhou S; Lockey T; Abdelsamed H; Cross SJ; Kang G; Ma Z; Condori J; Dowdy J; Triplett B; Li C; Maron G; Aldave Becerra JC; Church JA; Dokmeci E; Love JT; da Matta Ain AC; van der Watt H; Tang X; Janssen W; Ryu BY; De Ravin SS; Weiss MJ; Youngblood B; Long-Boyle JR; Gottschalk S; Meagher MM; Malech HL; Puck JM; Cowan MJ; Sorrentino BP
    N Engl J Med; 2019 Apr; 380(16):1525-1534. PubMed ID: 30995372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction of interleukin-2 receptor function in X-SCID lymphoblastoid cells by retrovirally mediated transfer of the gamma-c gene.
    Taylor N; Uribe L; Smith S; Jahn T; Kohn DB; Weinberg K
    Blood; 1996 Apr; 87(8):3103-7. PubMed ID: 8605323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy of X-linked severe combined immunodeficiency.
    Hacein-Bey-Abina S; Fischer A; Cavazzana-Calvo M
    Int J Hematol; 2002 Nov; 76(4):295-8. PubMed ID: 12463590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.